<DOC>
	<DOCNO>NCT01958229</DOCNO>
	<brief_summary>This study design support optimal use telbivudine provide data refine understanding telbivudine efficacy resistance real life clinical setting patient chronic hepatitis B define baseline characteristic 24-week PCR negativity .</brief_summary>
	<brief_title>Efficacy Study Telbivudine Chronic Hepatitis B Patients</brief_title>
	<detailed_description>This study multicenter , open-label observational data collection patient telbivudine meet baseline characteristic define majority patient see clinic setting . Data collection take place enrollment , Week 12 , 24 , 52 , 76 104 efficacy assessment . In patient discontinue observational drug earlier , clinical information would keep follow assessment well . Study purpose : This study design evaluate efficacy telbivudine real-life clinical setting use Roadmap Concept chronic hepatitis B treatment . Objectives : Primary : To observe telbivudine 's 2-year efficacy real-world clinical set achieve HBV-DNA &lt; 60 IU/ml HBeAg seroconversion rate patient define baseline characteristic 24-week treatment PCR negativity previously report GLOBE study 's sub-analysis . Secondary : 1 . To observe treatment outcome . 2 . To validate result super-responder trial . 3 . To validate Roadmap Concept . Population : The study population consist representative group 500 chronic hepatitis B patient detectable HBsAg 6 month need telbivudine therapy base investigator ' judgment 16 medical center locate Taiwan .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Telbivudine</mesh_term>
	<criteria>Male female 18 65 year age Documented chronic hepatitis B define ALL following : 1 . Clinical history compatible compensate chronic hepatitis B 2 . Detectable serum hepatitis B surface antigen ( HBsAg ) &gt; 6 month screen visit . Pregnant nursing coinfection hepatitis C virus ( HCV ) HIV Clinical image diagnosis cirrhosis Evidence decrease renal function creatinine &gt; ( = ) 2x ULN</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>